In 1985, recombinant human growth hormone was approved for the treatment of children with growth hormone deficiency. This therapeutic agent was among the first drugs to be produced by recombinant ...

The global human growth hormone market size was valued at USD 6.81 billion in 2024 and is projected to reach from USD 7.63 billion in 2025 to USD 18.75 billion by 2033, growing at a CAGR of 11.90% ...

On Medindia find the complete list of Growth Hormone drugs with their available forms and strength. More information is available on each drug including their price list. We recommend consulting ...

In April, 1985, the FDA banned the distribution of pituitary growth hormone (hGH) because of the possibility that it was contaminated by a “slow virus”. All parents of children receiving hGH ...

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users ...

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main goal.

A mathematical model suggests that existing HPA-targeting drugs failed in clinical trials for mood disorders because the ...

The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone therapy enzalutamide.